ScholarLens Back to search
2003•CHEST JournalRequires access

Effects of the Dual Endothelin Receptor Antagonist Bosentan in Patients With Pulmonary Arterial Hypertension

Olivier Sitbon, David B. Badesch, Richard N. Channick, Adaani Frost, Ivan M. Robbins, Gérald Simonneau, Victor F. Tapson, Lewis J. Rubin

Open publisher page 288 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 288 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Bosentan, Medicine, Endothelin receptor antagonist, Hemodynamics, Internal medicine, Cardiology, Placebo, Pulmonary hypertension

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Effects of the Dual Endothelin Receptor Antagonist Bosentan in Patients With Pulmonary Arterial Hypertension — Research Paper | ScholarLens